Nature aging

Reducing liver aging and fibrosis by targeting the chromatin regulator BAZ2B

Updated

Abstract

Upregulation of the chromatin remodeler BAZ2B is linked to metabolic dysfunction-associated steatohepatitis (MASH) pathology in patients.

  • Liver aging increases vulnerability to MASH with fibrosis.
  • The epigenetic mechanism involving BAZ2B connects liver aging to MASH fibrosis.
  • Genetic removal or targeted reduction of Baz2b in mice reduces hepatocyte senescence and MASH fibrosis.
  • Preservation of PPARα-mediated lipid metabolism is impaired in aged and MASH mouse livers.
  • BAZ2B downregulates PPARα signaling pathway genes by binding to their promoters and decreasing chromatin accessibility.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Competing interests: The authors declare no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free